Verastem VSTM Buy Opportunity

VSTM has a current median price target of $11.00 and Cantor Fitzgerald has reissued its Buy rating at a $17.00 price target. An ascending triangle is currently in formation which could suggest a near term break. The shares now sit on the base of the lower resistance line suggesting a good buy in opportunity for those willing to take on a high risk, high return position.